Home
BLCO
BLCO News

Latest Bausch + Lomb Corporation (BLCO) News on October 18, 2025

3 Unpopular Stocks Walking a Fine Line

StockStory

15 days ago

3 Unpopular Stocks Walking a Fine Line

BLCO vs. DHR: Which Stock Should Value Investors Buy Now?

Zacks

16 days ago

BLCO vs. DHR: Which Stock Should Value Investors Buy Now?

Investing.com

17 days ago

Goldman Sachs initiates ophthalmology coverage: Buy Glaukos, sell Cooper

Fuchs Endothelial Corneal Dystrophy Market Report 2025-2035: Bausch + Lomb, Santen Pharmaceutical, and Trefoil Therapeutics, Actively Shaping the Competitive Landscape

GlobeNewswire

17 days ago

Fuchs Endothelial Corneal Dystrophy Market Report 2025-2035: Bausch + Lomb, Santen Pharmaceutical, and Trefoil Therapeutics, Actively Shaping the Competitive Landscape

Bausch + Lomb (BLCO) Stock Trades Up, Here Is Why

StockStory

a month ago

Bausch + Lomb (BLCO) Stock Trades Up, Here Is Why

Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States

Business Wire

a month ago

Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States

3 Healthcare Stocks Walking a Fine Line

StockStory

a month ago

3 Healthcare Stocks Walking a Fine Line

Bausch + Lomb (BLCO) Stock Is Up, What You Need To Know

StockStory

2 months ago

Bausch + Lomb (BLCO) Stock Is Up, What You Need To Know

Purple, Bausch + Lomb, Etsy, Intel, and Camping World Shares Are Falling, What You Need To Know

StockStory

2 months ago

Purple, Bausch + Lomb, Etsy, Intel, and Camping World Shares Are Falling, What You Need To Know

Medical Devices & Supplies - Specialty Stocks Q2 Highlights: Bausch + Lomb (NYSE:BLCO)

StockStory

2 months ago

Medical Devices & Supplies - Specialty Stocks Q2 Highlights: Bausch + Lomb (NYSE:BLCO)

MT Newswires

4 months ago

Bausch + Lomb Closes Floating Rate Note Offering, Refinances Credit Facilities

MT Newswires

4 months ago

Bausch + Lomb Closes Senior Secured Notes Offering, Refinancing And Upsizes US$2.32 Billion Term Loan Facility

Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility

Business Wire

4 months ago

Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility

The Top 5 Analyst Questions From Bausch + Lomb’s Q1 Earnings Call

StockStory

4 months ago

The Top 5 Analyst Questions From Bausch + Lomb’s Q1 Earnings Call

Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June

Insider Monkey

4 months ago

Barclays Cut Bausch & Lomb Target to $16, Keeping Rating Neutral in Early June

MT Newswires

4 months ago

Bausch + Lomb Prices Upsizes and Prices a 675-Million Euro Senior Secured Notes Offering

Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering

Business Wire

4 months ago

Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering

Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement

Business Wire

4 months ago

Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement

Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States

Business Wire

4 months ago

Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States

1 Safe-and-Steady Stock for Long-Term Investors and 2 to Question

StockStory

4 months ago

1 Safe-and-Steady Stock for Long-Term Investors and 2 to Question

Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference

Business Wire

5 months ago

Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference

Bausch + Lomb Announces 2025 Annual Meeting of Shareholders Results

Business Wire

5 months ago

Bausch + Lomb Announces 2025 Annual Meeting of Shareholders Results

Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States

Business Wire

5 months ago

Bausch + Lomb Launches New LUMIFY® Preservative Free Redness Reliever Eye Drops in the United States

Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States

Business Wire

5 months ago

Bausch + Lomb Launches Zenlens® CHROMA HOA™ in the United States

BLCO Q1 Earnings Call: Misses on Profit, Highlights Product Innovation and Tariff Uncertainty

StockStory

5 months ago

BLCO Q1 Earnings Call: Misses on Profit, Highlights Product Innovation and Tariff Uncertainty

Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens

Business Wire

5 months ago

Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens

GuruFocus.com

6 months ago

Bausch & Lomb Corp (BLCO) Q1 2025 Earnings Call Highlights: Navigating Growth Amid Challenges

Morningstar Research

6 months ago

Analyst Report: Bausch + Lomb Corporation

Why Bausch + Lomb (BLCO) Shares Are Falling Today

StockStory

6 months ago

Why Bausch + Lomb (BLCO) Shares Are Falling Today

Bausch + Lomb (NYSE:BLCO) Misses Q1 Sales Targets, Stock Drops 10.4%

StockStory

6 months ago

Bausch + Lomb (NYSE:BLCO) Misses Q1 Sales Targets, Stock Drops 10.4%

Bausch + Lomb Announces First-Quarter 2025 Results

Business Wire

6 months ago

Bausch + Lomb Announces First-Quarter 2025 Results

Bausch + Lomb (BLCO) Reports Q1: Everything You Need To Know Ahead Of Earnings

StockStory

6 months ago

Bausch + Lomb (BLCO) Reports Q1: Everything You Need To Know Ahead Of Earnings

Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall

Business Wire

6 months ago

Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall

Morningstar Research

6 months ago

Analyst Report: Bausch + Lomb Corporation

Is Bausch + Lomb (BLCO) the Most Undervalued Canadian Stock to Buy According to Wall Street Analysts?

Insider Monkey

6 months ago

Is Bausch + Lomb (BLCO) the Most Undervalued Canadian Stock to Buy According to Wall Street Analysts?

Bausch Health Companies Inc (BHC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

6 months ago

Bausch Health Companies Inc (BHC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Bausch + Lomb Reports More Than 100 Million Units of Contacts Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

Business Wire

6 months ago

Bausch + Lomb Reports More Than 100 Million Units of Contacts Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

3 Reasons to Sell BLCO and 1 Stock to Buy Instead

StockStory

6 months ago

3 Reasons to Sell BLCO and 1 Stock to Buy Instead

Morningstar Research

6 months ago

Analyst Report: Bausch + Lomb Corporation

Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment

StockStory

6 months ago

Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment

Morningstar Research

6 months ago

Analyst Report: Bausch + Lomb Corporation

Mag 7 slide, gold rises, Bausch + Lomb recall: Market Minute

Yahoo Finance Video

7 months ago

Mag 7 slide, gold rises, Bausch + Lomb recall: Market Minute

Why Bausch + Lomb (BLCO) Shares Are Plunging Today

StockStory

7 months ago

Why Bausch + Lomb (BLCO) Shares Are Plunging Today

Why Bausch + Lomb (BLCO) Stock Is Nosediving

StockStory

7 months ago

Why Bausch + Lomb (BLCO) Stock Is Nosediving

Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista Envy™ and Certain enVista® Monofocal Intraocular Lenses

Business Wire

7 months ago

Bausch + Lomb Announces Voluntary Recall of enVista Aspire™, enVista Envy™ and Certain enVista® Monofocal Intraocular Lenses

Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30

Business Wire

7 months ago

Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30

Bausch + Lomb Launches Arise™ Orthokeratology Lens System in the United States

Business Wire

7 months ago

Bausch + Lomb Launches Arise™ Orthokeratology Lens System in the United States

How DOGE's 'transparency' could be applied to healthcare

Yahoo Finance Video

8 months ago

How DOGE's 'transparency' could be applied to healthcare

Bausch + Lomb Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

8 months ago

Bausch + Lomb Full Year 2024 Earnings: EPS Misses Expectations

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Bausch + Lomb Corp Earnings Call

GuruFocus.com

8 months ago

Bausch & Lomb Corp (BLCO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Morningstar Research

8 months ago

Analyst Report: Bausch + Lomb Corporation

Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent

Yahoo Finance

8 months ago

Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent

Bausch + Lomb to shake up contact lenses with deal off the table

Yahoo Finance Video

8 months ago

Bausch + Lomb to shake up contact lenses with deal off the table

Bausch + Lomb’s (NYSE:BLCO) Q4: Beats On Revenue

StockStory

8 months ago

Bausch + Lomb’s (NYSE:BLCO) Q4: Beats On Revenue

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance

Business Wire

8 months ago

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2024 Results, Provides 2025 Guidance

GuruFocus.com

8 months ago

Bausch & Lomb Corp (TSX:BLCO) Q4 2024: Everything You Need To Know Ahead Of Earnings

Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect

StockStory

8 months ago

Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect

Morningstar Research

8 months ago

Analyst Report: Bausch + Lomb Corporation

Bausch + Lomb Provides Update on Potential Sale

Business Wire

8 months ago

Bausch + Lomb Provides Update on Potential Sale

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19

Business Wire

9 months ago

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February 19

This Bausch + Lomb Insider Increased Their Holding In The Last Year

Simply Wall St.

9 months ago

This Bausch + Lomb Insider Increased Their Holding In The Last Year

Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences

Business Wire

9 months ago

Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences

Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union

Business Wire

9 months ago

Bausch + Lomb Launches enVista Aspire™ Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union

Is Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20?

Insider Monkey

9 months ago

Is Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20?

Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual "Faces of Glaucoma" Campaign and Fundraising Challenge

Business Wire

9 months ago

Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual "Faces of Glaucoma" Campaign and Fundraising Challenge

Bausch + Lomb price target lowered to $22 from $25 at Evercore ISI

TipRanks

9 months ago

Bausch + Lomb price target lowered to $22 from $25 at Evercore ISI

Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Business Wire

10 months ago

Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Investing.com

10 months ago

BofA rates Bausch & Lomb ‘underperform’ with lower buyout chances

Bausch + Lomb Responds to Rumors of a Potential Sale

Business Wire

10 months ago

Bausch + Lomb Responds to Rumors of a Potential Sale

Morningstar Research

10 months ago

Analyst Report: Bausch + Lomb Corporation

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Business Wire

10 months ago

Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities

Bausch & Lomb Corporation (BLCO)-A Bull Case Theory

Insider Monkey

a year ago

Bausch & Lomb Corporation (BLCO)-A Bull Case Theory

Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

Business Wire

a year ago

Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

Bausch + Lomb Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a year ago

Bausch + Lomb Third Quarter 2024 Earnings: Beats Expectations

GuruFocus.com

a year ago

Bausch & Lomb Corp (BLCO) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Morningstar Research

a year ago

Analyst Report: Bausch + Lomb Corporation

Bausch + Lomb Announces Third-Quarter 2024 Results

Business Wire

a year ago

Bausch + Lomb Announces Third-Quarter 2024 Results

Bausch & Lomb Corp (TSX:BLCO) Q3 2024 Earnings Report Preview: What To Look For

GuruFocus.com

a year ago

Bausch & Lomb Corp (TSX:BLCO) Q3 2024 Earnings Report Preview: What To Look For

Bausch + Lomb price target raised to $23 from $20 at RBC Capital

TipRanks

a year ago

Bausch + Lomb price target raised to $23 from $20 at RBC Capital

Morningstar Research

a year ago

Analyst Report: Bausch + Lomb Corporation

Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens

Business Wire

a year ago

Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens

Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30

Business Wire

a year ago

Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30

Bausch + Lomb price target raised to $19 from $17 at Evercore ISI

TipRanks

a year ago

Bausch + Lomb price target raised to $19 from $17 at Evercore ISI

Bausch + Lomb Launches Opal™ Digital Marketplace in the United States

Business Wire

a year ago

Bausch + Lomb Launches Opal™ Digital Marketplace in the United States

Morningstar Research

a year ago

Analyst Report: Bausch + Lomb Corporation

Morningstar Research

a year ago

Analyst Report: Bausch + Lomb Corporation

Stocks to Watch Monday: DJT, Apple, Pfizer, Intel

The Wall Street Journal

a year ago

Stocks to Watch Monday: DJT, Apple, Pfizer, Intel

Investing.com

a year ago

Bausch + Lomb explores sale amid parent company's debt woes - report

Bausch + Lomb Insider Ups Holding During Year

Simply Wall St.

a year ago

Bausch + Lomb Insider Ups Holding During Year

Insider Buying: CEO Brent Saunders Acquires Shares of Bausch & Lomb Corp

GuruFocus.com

a year ago

Insider Buying: CEO Brent Saunders Acquires Shares of Bausch & Lomb Corp

Morningstar Research

a year ago

Analyst Report: Bausch + Lomb Corporation

Morningstar Research

a year ago

Analyst Report: Bausch + Lomb Corporation

Bausch + Lomb Announces Second-Quarter 2024 Results

Business Wire

a year ago

Bausch + Lomb Announces Second-Quarter 2024 Results

Morningstar Research

a year ago

Analyst Report: Bausch + Lomb Corporation

Morningstar Research

a year ago

Analyst Report: Bausch + Lomb Corporation

Morningstar Research

a year ago

Analyst Report: Bausch + Lomb Corporation

Morningstar Research

a year ago

Analyst Report: Bausch + Lomb Corporation

Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31

Business Wire

a year ago

Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31

Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief

Business Wire

a year ago

Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief

Share on Social Networks: